Literature DB >> 35258762

Integrated analysis of gut microbiome and host immune responses in COVID-19.

Xiaoguang Xu1, Wei Zhang1,2, Mingquan Guo3, Chenlu Xiao4, Ziyu Fu1, Shuting Yu1, Lu Jiang1, Shengyue Wang1, Yun Ling3, Feng Liu1, Yun Tan5, Saijuan Chen6.   

Abstract

Emerging evidence indicates that the gut microbiome contributes to the host immune response to infectious diseases. Here, to explore the role of the gut microbiome in the host immune responses in COVID-19, we conducted shotgun metagenomic sequencing and immune profiling of 14 severe/critical and 24 mild/moderate COVID-19 cases as well as 31 healthy control samples. We found that the diversity of the gut microbiome was reduced in severe/critical COVID-19 cases compared to mild/moderate ones. We identified the abundance of some gut microbes altered post-SARS-CoV-2 infection and related to disease severity, such as Enterococcus faecium, Coprococcus comes, Roseburia intestinalis, Akkermansia muciniphila, Bacteroides cellulosilyticus and Blautia obeum. We further analyzed the correlation between the abundance of gut microbes and host responses, and obtained a correlation map between clinical features of COVID-19 and 16 severity-related gut microbe, including Coprococcus comes that was positively correlated with CD3+/CD4+/CD8+ lymphocyte counts. In addition, an integrative analysis of gut microbiome and the transcriptome of peripheral blood mononuclear cells (PBMCs) showed that genes related to viral transcription and apoptosis were up-regulated in Coprococcus comes low samples. Moreover, a number of metabolic pathways in gut microbes were also found to be differentially enriched in severe/critical or mild/moderate COVID-19 cases, including the superpathways of polyamine biosynthesis II and sulfur oxidation that were suppressed in severe/critical COVID-19. Together, our study highlighted a potential regulatory role of severity related gut microbes in the immune response of host.
© 2022. Higher Education Press.

Entities:  

Keywords:  COVID-19; SARS-COV-2; gut microbiome; immune response

Mesh:

Year:  2022        PMID: 35258762      PMCID: PMC8902486          DOI: 10.1007/s11684-022-0921-6

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   9.927


Supplementary material, approximately 18.6 KB. Supplementary material, approximately 1.51 MB. Supplementary material, approximately 72.5 KB. Supplementary material, approximately 49.0 KB. Supplementary material, approximately 35.0 KB. Supplementary material, approximately 36.5 KB. Supplementary material, approximately 107 KB.
  44 in total

1.  Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota.

Authors:  Stephanie C Ganal; Stephanie L Sanos; Carsten Kallfass; Karin Oberle; Caroline Johner; Carsten Kirschning; Stefan Lienenklaus; Siegfried Weiss; Peter Staeheli; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2012-06-28       Impact factor: 31.745

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

Review 3.  Gut microbial metabolites as multi-kingdom intermediates.

Authors:  Kimberly A Krautkramer; Jing Fan; Fredrik Bäckhed
Journal:  Nat Rev Microbiol       Date:  2020-09-23       Impact factor: 60.633

4.  Commensal bacteria calibrate the activation threshold of innate antiviral immunity.

Authors:  Michael C Abt; Lisa C Osborne; Laurel A Monticelli; Travis A Doering; Theresa Alenghat; Gregory F Sonnenberg; Michael A Paley; Marcelo Antenus; Katie L Williams; Jan Erikson; E John Wherry; David Artis
Journal:  Immunity       Date:  2012-06-14       Impact factor: 31.745

5.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Authors:  Rohit Loomba; Victor Seguritan; Weizhong Li; Tao Long; Niels Klitgord; Archana Bhatt; Parambir Singh Dulai; Cyrielle Caussy; Richele Bettencourt; Sarah K Highlander; Marcus B Jones; Claude B Sirlin; Bernd Schnabl; Lauren Brinkac; Nicholas Schork; Chi-Hua Chen; David A Brenner; William Biggs; Shibu Yooseph; J Craig Venter; Karen E Nelson
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

6.  Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response.

Authors:  M Zhang; T Caragine; H Wang; P S Cohen; G Botchkina; K Soda; M Bianchi; P Ulrich; A Cerami; B Sherry; K J Tracey
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

7.  Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis.

Authors:  Changxin Zhu; Kerui Song; Zhaohua Shen; Yongsheng Quan; Bei Tan; Weiwei Luo; Shuai Wu; Kai Tang; Zhenyu Yang; Xiaoyan Wang
Journal:  Mol Med Rep       Date:  2018-03-29       Impact factor: 2.952

8.  Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Authors:  Clara Depommier; Amandine Everard; Céline Druart; Hubert Plovier; Matthias Van Hul; Sara Vieira-Silva; Gwen Falony; Jeroen Raes; Dominique Maiter; Nathalie M Delzenne; Marie de Barsy; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

9.  Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.

Authors:  Wanyin Tao; Guorong Zhang; Xiaofang Wang; Meng Guo; Weihong Zeng; Zhihao Xu; Dan Cao; Aijun Pan; Yucai Wang; Kaiguang Zhang; Xiaoling Ma; Zhengxu Chen; Tengchuan Jin; Lianxin Liu; Jianping Weng; Shu Zhu
Journal:  Med Microecol       Date:  2020-09-28

10.  Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.

Authors:  Yun Tan; Feng Liu; Xiaoguang Xu; Yun Ling; Weijin Huang; Zhaoqin Zhu; Mingquan Guo; Yixiao Lin; Ziyu Fu; Dongguo Liang; Tengfei Zhang; Jian Fan; Miao Xu; Hongzhou Lu; Saijuan Chen
Journal:  Front Med       Date:  2020-10-05       Impact factor: 4.592

View more
  4 in total

Review 1.  SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction.

Authors:  Stelios F Assimakopoulos; Gerasimos Eleftheriotis; Maria Lagadinou; Vassilios Karamouzos; Periklis Dousdampanis; Georgios Siakallis; Markos Marangos
Journal:  Microorganisms       Date:  2022-05-19

Review 2.  Role of Microbiota in Viral Infections and Pathological Progression.

Authors:  Taketoshi Mizutani; Aya Ishizaka; Michiko Koga; Takeya Tsutsumi; Hiroshi Yotsuyanagi
Journal:  Viruses       Date:  2022-05-01       Impact factor: 5.818

3.  Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential "Next Generation Probiotic".

Authors:  Chao Zhang; Kejia Ma; Kai Nie; Minzi Deng; Weiwei Luo; Xing Wu; Yujun Huang; Xiaoyan Wang
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

4.  Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes.

Authors:  Shanlin Ke; Scott T Weiss; Yang-Yu Liu
Journal:  Nat Commun       Date:  2022-09-06       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.